76 related articles for article (PubMed ID: 7110971)
21. Effects of sublingual isosorbide dinitrate on left ventricular performance during exercise in patients with myocardial infarction.
Fukui S; Satoh K; Tanaka T; Inoue H; Hamano Y; Katoh O; Minamino T; Fujii K; Satoh H; Inoue M
Jpn Circ J; 1984 Oct; 48(10):1057-65. PubMed ID: 6492371
[TBL] [Abstract][Full Text] [Related]
22. Intravenous isosorbide dinitrate in acute left ventricular failure--a dose--response study.
Gwilt DJ; Petri M; Reid DS
Eur Heart J; 1983 Oct; 4(10):712-7. PubMed ID: 6653581
[TBL] [Abstract][Full Text] [Related]
23. Oral ISDN for the treatment of patients with acute myocardial infarction.
Grosser KD; Schuster P; Freund M; Knoch K; Sturm A
Z Kardiol; 1983; 72 Suppl 3():147-51. PubMed ID: 6666216
[TBL] [Abstract][Full Text] [Related]
24. Vasodilator therapy for acute heart failure: haemodynamic comparison of hydralazine/isosorbide, alpha-adrenoceptor blockade, and angiotensin-converting enzyme inhibition.
Verma SP; Silke B; Reynolds GW; Kelly JG; Richmond A; Taylor SH
J Cardiovasc Pharmacol; 1992 Aug; 20(2):274-81. PubMed ID: 1381019
[TBL] [Abstract][Full Text] [Related]
25. Radionuclear measurement of peripheral hemodynamics in selection of vasodilators for treatment of heart failure.
Todo Y; Ohyanagi M; Fujisue R; Iwasaki T
J Nucl Med; 1988 Apr; 29(4):451-9. PubMed ID: 3351600
[TBL] [Abstract][Full Text] [Related]
26. Nitrate therapy for left ventricular failure complicating acute myocardial infarction: a haemodynamic comparison of intravenous, buccal, and transdermal delivery systems.
Verma SP; Silke B; Reynolds GW; Richmond A; Taylor SH
J Cardiovasc Pharmacol; 1989 Nov; 14(5):756-62. PubMed ID: 2481190
[TBL] [Abstract][Full Text] [Related]
27. Advantage of combined therapy with captopril and nitrates in severe congestive heart failure.
Halon DA; Rosenfeld T; Hardoff R; Lewis BS
Isr J Med Sci; 1988 Nov; 24(11):664-70. PubMed ID: 3063685
[TBL] [Abstract][Full Text] [Related]
28. Nitrate tolerance: hemodynamic effects of intravenous isosorbide dinitrate after sustained oral isosorbide dinitrate administration.
Kumagae H; Koiwaya Y; Tanaka K
Clin Ther; 1990; 12(1):31-43. PubMed ID: 2328526
[TBL] [Abstract][Full Text] [Related]
29. [Influence of isosorbiddinitrate on hemodynamics at rest and during exercise (author's transl)].
Spiel R; Dittel M; Kiss E; Nobis H; Prachar H; Spiel C; Enenkel W
Z Kardiol; 1980 Jun; 69(6):444-51. PubMed ID: 7445646
[TBL] [Abstract][Full Text] [Related]
30. Effects of isosorbide dinitrate spray on central hemodynamics. Comparison with sublingual glyceryl trinitrate and isosorbide dinitrate.
Saito M; Fukami K; Sumiyoshi T; Haze K; Hiramori K
Arzneimittelforschung; 1984; 34(6):707-9. PubMed ID: 6435644
[TBL] [Abstract][Full Text] [Related]
31. Haemodynamic advantages of isosorbide dinitrate over frusemide in acute heart-failure following myocardial infarction.
Nelson GI; Silke B; Ahuja RC; Hussain M; Taylor SH
Lancet; 1983 Apr; 1(8327):730-3. PubMed ID: 6132082
[TBL] [Abstract][Full Text] [Related]
32. [Hemodynamic action of isosorbide-5-mononitrate during rapid venous administration in patients with acute myocardial infarct].
Daskalov T
Vutr Boles; 1988; 27(2):26-33. PubMed ID: 3414098
[TBL] [Abstract][Full Text] [Related]
33. Intravenous isosorbide dinitrate in patients with refractory pump failure and acute myocardial infarction.
Rabinowitz B; Tamari I; Elazar E; Neufeld HN
Circulation; 1982 Apr; 65(4):771-8. PubMed ID: 7060256
[TBL] [Abstract][Full Text] [Related]
34. [Efficacy of a new slow-release isosorbide dinitrate preparation in myocardial infarction (author's transl)].
Stein G; Glocke M; Teufel W
Med Klin; 1975 Jul; 70(27):1179-84. PubMed ID: 1177789
[TBL] [Abstract][Full Text] [Related]
35. [Effect of captopril in left ventricular failure during the acute stage of myocardial infarction].
Kayanakis JG; Breton J; Maillet J; Fauvel JM; Bounhoure JP
Arch Mal Coeur Vaiss; 1983 Dec; 76(12):1369-74. PubMed ID: 6422872
[TBL] [Abstract][Full Text] [Related]
36. Haemodynamic comparison of different routes of nitrate administration in postmyocardial infarction left ventricular failure.
Taylor SH; Verma SP; Silke B
Z Kardiol; 1989; 78 Suppl 2():133-6; discussion 142-4. PubMed ID: 2511687
[TBL] [Abstract][Full Text] [Related]
37. Haemodynamic effects of intravenous isosorbide-5-mononitrate in acute and chronic left heart failure of ischaemic aetiology.
Rabinowitz B; Katz A; Shotan A; Chouraqui P; Neufeld HN
Eur Heart J; 1988 Jan; 9 Suppl A():175-80. PubMed ID: 3409914
[TBL] [Abstract][Full Text] [Related]
38. [Long-term haemodynamic effect of high doses of isosorbid dinitrate (80 mg) in slow-release form in coronary heart disease (author's transl)].
Wolf R; Sinn R; Guillen R; Koeffler H
Dtsch Med Wochenschr; 1981 Sep; 106(36):1130-4. PubMed ID: 7261938
[No Abstract] [Full Text] [Related]
39. [Orally active vasodilators in the management of chronic treatment-resistant cardiac failure (author's transl)].
Wirtzfeld A; Klein G; Himmler FC; Schmidt G; Kutschera I; Sauer E
Dtsch Med Wochenschr; 1980 Oct; 105(40):1379-83. PubMed ID: 7449633
[TBL] [Abstract][Full Text] [Related]
40. [Effects of intravenous infusion of isosorbide dinitrate (ISDN) on acute experimental congestive heart failure].
Ohhara H; Takeda M; Igarashi T
Nihon Yakurigaku Zasshi; 1983 Nov; 82(5):343-50. PubMed ID: 6671626
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
